DocGo Inc. is a healthcare services company that provides mobile health, virtual care, and medical transportation solutions. The company operates through three reporting segments: Mobile Health Services, Transportation Services, and Corporate. Its Mobile Health Services segment delivers on-site evaluation, diagnostics, triage, and treatment in patients' homes and workplaces, utilizing a network of licensed practical nurses, registered nurses, and advanced practice providers. The company also offers virtual care management, remote patient monitoring, and white-label telehealth services. DocGo serves municipalities, hospital networks, health insurance providers, physician practices, and employers across all 50 U.S. states and the United Kingdom. Notable partnerships include NYC Health + Hospitals, the U.S. Department of Veterans Affairs, the Indian Health Service, and the National Health Service. The company was founded in 2015 and acquired a 50-state virtual care network and a mobile phlebotomy provider in 2025.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Care Facilities Homepage docgo.com
Sector Healthcare IR page ir.docgo.com
Tags
mobile health, virtual care, telehealth, medical transportation, remote patient monitoring, care gap closure, population health, chronic disease management, mobile phlebotomy, value-based care, Mobile Medical Healthcare P.C., Hicuity Health, SteadyMD, Project Mariel
Press page ir.docgo.com/pressreleases

Metrics

Valuation  
Market cap $ 39.577M
Market cap (USD) $ 39.577M
P/E -0.22
PEG —
P/BV 0.38
P/S 0.13
P/OCF -1.41
P/FCF -1.30
Dividend yield —
Turnover / mcap —
Returns  
ROE -78.5%
ROI -126.4%
ROIC -92.6%
Profit margin -56.6%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock Yes
Diluting (TTM) Yes
Debt/Equity 0.19%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 10
Quality score -70.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 322.196M 616.555M 624.289M 440.516M 318.719M 94.091M
Net profit -182.4M 13.361M 10.048M 34.584M 19.179M -14.799M
Free cash flow 29.908M 66.503M -71.806M 25.672M -6.756M -15.016M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 0.88 4.24 5.59 7.07 9.35 —
Price performance 12m -0.79 -0.24 -0.21 -0.24 — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — 78.4M 103M 262M 211M 92.9M
↳ YoY growth +31.4% +154.5% -19.5% -56.0%
Borrowings, current (USD) — — 600,449 664,913 28,131 12,515 51,740
Borrowings, non-current (USD) — — — — 41,586 5,215 183,843
Lease liabilities (USD) — 12.6M 14.6M 18M 21.4M 27.2M 28.9M
Cash and deposits (USD) 51.8M 878,653 176M 157M 59.3M 89.2M 51M
Intangible assets (USD) — 10.7M 10.7M 23M 37.7M 25.7M 0.00
Right-of-use assets (USD) — 5M 4.2M 9.07M 9.58M 12M 11.5M
Net debt (borrowings + leases - cash) (USD) — — -160M -139M -37.8M -62.1M -21.8M
Cash flow detail
Operating cash flow (USD) — -10.7M -1.95M 28.9M -64.2M 70.3M 34.5M
Purchases of property, plant and equipment (USD) — -4.36M -4.81M -3.2M -7.58M -3.83M -4.54M
Purchases of intangible assets (USD) — -1.95M -1.85M -2.3M -2.54M -2M -2.89M
Change in receivables (cash effect) (USD) — -16.2M -58M -8.42M -161M 41.3M 112M
Change in payables (cash effect) (USD) — 3.01M 11.9M 3.64M -1.78M 8.56M -17.6M
Share buybacks (cash effect) (USD) — — 0.00 -3.73M 0.00 -13.8M -10.8M
Interest paid (cash effect) (USD) — — -315,272 -197,005 -250,100 -2.14M -1.71M
Income taxes paid (cash effect) (USD) — -117,443 -615,697 -1.51M -4.25M -7.25M -6.48M
Share-based compensation (USD) — — 1.38M 8.05M 21M 13.6M 17.4M
Operating cash flow before change in receivables (USD) — 5.5M 56M 37.3M 96.3M 29.1M -78M
Free cash flow (OCF - PPE - intangibles) (USD) — -17M -8.6M 23.4M -74.3M 64.5M 27M
Income detail
Research and development expense (USD) — 1.19M 3.32M 5.38M 10.9M 11.6M 13.6M
↳ 5y CAGR +62.7%
Total comprehensive income (USD) — -14.2M 23.8M 35.4M 7.6M 19.7M -181M
Comprehensive income to owners (USD) — -14.2M 23.8M 35.4M 7.6M 19.7M -181M
Provision for credit losses (USD) — 1.89M 4.47M 3.82M 3.6M 5.24M 12M
Credit cost ratio (credit losses / average receivables) (%) — — — 4.2% 2.0% 2.2% 7.9%
Reported Mar 15, 2022 Mar 15, 2022 Feb 28, 2024 Feb 28, 2024 Feb 28, 2024 Feb 27, 2025 Mar 16, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

As previously announced, DocGo Inc. (the “Company”) is conducting a search for a new Chief Executive Officer as the employment agreement of the Company’s current CEO, Lee Bienstock, expires December 31, 2026.

On November 13, 2026, the Company and Mr. Bienstock entered into a Transition Services and Separation Agreement (the “Transition Agreement”), pursuant to which Mr. Bienstock will continue to serve as the Company’s Chief Executive Officer (“CEO”) and provide assistance in transitioning the role from January 1, 2027 through March 31, 2027, or such later date as may mutually be agreed by the parties (the “Transition Period”). If a successor CEO commences employment prior to March 31, 2027 (the “Separation Date”), Mr. Bienstock will continue to serve as a senior advisor to the board and the successor CEO through the Separation Date.

As consideration for his continued service during the Transition Period and subject to the terms of the Transition Agreement, Mr.

On November 9, 2026, DocGo Inc. (the “Company”) issued a press release announcing the Company’s earnings results for the quarter ended September 30, 2026 (the “Press Release”). The Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this “Report”).

As previously announced, the Company will also hold a conference call and webcast at 5:00 p.m. Eastern Time on November 9, 2026 to discuss its earnings results for the quarter ended September 30, 2026 (the “Conference Call”).

During the Conference Call, the Company’s management intends to report adjusted gross margin, adjusted EBITDA, and adjusted operating expenses, which are financial measures that are not calculated or presented in accordance with generally accepted accounting principles (“GAAP”). Information regarding adjusted gross margin, adjusted EBITDA, and adjusted operating expenses, and reconciliations to the most directly comparable financial measure calculated and presented in accordance with GAAP are included in Exhibit 99.2 to this Report.

Amended and Restated Credit Agreement and Guaranty

On October 1, 2026, Hicuity and Ambulnz (together, the "Borrowers"), DocGo, certain subsidiaries of Ambulnz as guarantors, the lenders from time to time party thereto (the "Lenders") and Perceptive Credit Holdings IV, LP, as administrative agent (the "Administrative Agent"), entered into an Amended and Restated Credit Agreement and Guaranty (the "Credit Agreement"), which amends and restates in its entirety that certain Credit Agreement and Guaranty of Hicuity, dated as of December 6, 2022, as previously amended. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement.

The Credit Agreement provides for the following credit facilities (the “Term Loans”):
•Term Loan A: The existing term loans outstanding under the prior credit agreement are continued as Outstanding Term Loans under the Credit Agreement in the aggregate amount of $52,000,000. •Term Loan B: A new term loan facility in an aggregate principal amount of $12,500,000, to be funded on the effective date of the Credit Agreement.

Prompts

DocGo Inc. (ticker DCGO), listed in United States.

Company History

Date Change Detail
Jul 29, 2021 Renamed MOTION ACQUISITION CORP. → DOCGO INC.

ETFs Holding DocGo Inc.

ETF Weight in ETF Shares Market value As of
BSVO 0.00% 103,835 $ 20K Nov 18, 2026